The Serum Institute of India has allegedly reduced the rates of their vaccine Covishield. While it must be noted that the CEO of Serum Institute, Adar Poonawala shared the information on Wednesday stating that, the company has now priced its vaccine at Rs. 300 instead of Rs. 400.
Sharing the cause behind the step taken, Adar said that reducing the rates of vaccines being sent to the state government will save crores of rupees which can otherwise be used in the welfare of people and getting through these difficult times.
Earlier, the rates of vaccines prescribed by the Serum Institute on 21st April 2021 were Rs. 400 per dose for the state government and Rs. 600 per dose for the private hospitals.
As of now, India is using Covaxin and Covishield vaccines to vaccinate citizens. However, the Sputnik V vaccine which was recently approved is expected to reach India by 1st May 2021.